More details
13.10.06

2006 3rd quarter: sales up 9%

 

€ millions

 2006

 2005

 % change

Q3 Sales

24.89

22.76

9%

France, including overseas dependencies

11.96

10.83

10%

Subsidiaries (1)

  9.73

  8.88

10%

Distributors

  3.20

 3.05

  5%

Cumulative sales at end September

89.09

78.89

13%

France, including overseas dependencies

47.18

41.61

13%

Subsidiaries (1)

31.96

28.44

12%

Distributors

  9.95

  8.84

 

(1)Germany, Belgium, Italy, Spain and Portugal.


3rd quarter growth was in keeping with 2nd quarter growth.

In France, the increase in sales remained satisfactory (up 10%) and new patients continued to be attracted.

Even though subsidiary growth remained at a good level (up 10%), it was also more uneven: sales growth slowed down in Germany in a sluggish market, whereas Spain fully benefited from the successful integration of IPI.

The traditionally more volatile distributor segment slowed down as expected (up 5%) following two quarters of strong growth.

Cumulative growth at end September was 13% (of which 12% was organic).  As forecast, full year growth should exceed 10% for the sixth year running.